Previous close | 167.44 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 793 |
Market cap | 154.62M |
Beta (5Y monthly) | 1.26 |
PE ratio (TTM) | 0.15 |
EPS (TTM) | 11.50 |
Earnings date | 23 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Universal Health Services (UHS) could produce exceptional returns because of its solid growth attributes.
Continued solid uptake of BD's (BDX) products is expected to have driven fiscal second-quarter revenues.
Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.